retatrutide approval status 2025 fda ema The 'Miracle Drug' and the Peptide Craze Breaking the Retatrutide vs Tirzepatide (2026): Differences

The optimal timing for GLP-1 injections depends primarily on the specific formulation you have been prescribed, rather than a universal rule applying to all GLP-1 medications

Retatrutides phase 3 topline data reported adverse events broadly consistent with incretin-based therapies, with nausea, diarrhea, constipation, and vomiting among the most common

You can determine your eligibility by taking our free assessment quiz, which evaluates your health history and weight loss goals

The key is staying in communication with your prescriber rather than trying to self-adjust either medication

no real-time or emergency access